Literature DB >> 6759797

The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation.

C N Boyd, R C Ramberg, E D Thomas.   

Abstract

A total of 243 patients with acute leukemia received a marrow graft from a donor of the opposite sex. Seventy-five patients subsequently relapsed, and specimens of the recurrent leukemia cells were available for cytogenetic analysis in 54. Three relapses were in donor-type cells. Four patients whose relapses were in host-type cells showed a cytogenic abnormality that differed from the original leukemic clone. We conclude that a 'new' leukemia in donor cells, and possibly in host cells, constitutes a small but significant fraction of recurrent leukemia after marrow grafting.

Entities:  

Mesh：

Year:  1982        PMID： 6759797     DOI： 10.1016/0145-2126(82)90067-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  16 in total

Review 1.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

2.  Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia.

Authors:  Satoshi Hashino; Fumie Fujisawa; Takeshi Kondo; Masahiro Imamura; Kazuya Sato; Yoshihiro Torimoto; Yutaka Kohgo; Keisuke Kimura; Hiroyuki Furukawa; Satoru Todo; Masahiro Asaka
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 3.  Molecular analysis of Philadelphia chromosome positive leukaemias.

Authors:  B D Young
Journal:  Br J Cancer Suppl       Date:  1988-12

Review 4.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

5.  Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Authors:  Robbie G Majzner; Huzefa Mogri; Ravi Varadhan; Patrick Brown; Kenneth R Cooke; Javier Bolaños-Meade; Lode Swinnen; Jennifer Kanakry; Leo Luznik; Richard J Jones; Ephraim Fuchs; Rich Ambinder; Yvette Kasamon; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-03       Impact factor: 5.742

6.  Cytogenetic studies in bone marrow transplant recipients.

Authors:  O A Haas; W Hinterberger; W Schmidmeier; C Pollak; M Hinterberger; H Gadner; K Lechner
Journal:  Blut       Date:  1986-07

7.  Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism.

Authors:  M D Minden; H A Messner; A Belch
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 8.  Risks and mechanisms of oncological disease following stem cell transplantation.

Authors:  Sergey V Anisimov; Asuka Morizane; Ana S Correia
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

9.  Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

10.  Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.

Authors:  Toshinori Kondo; Taizo Tasaka; Risa Shimizu; Kiyohito Hayashi; Seiko Yamada; Hirofumi Fukuda; Tadashi Hirose; Asako Takeuchi; Fuminori Sano; Hirotoshi Tokunaga; Yoshiko Matsuhashi; Hideho Wada
Journal:  Mol Clin Oncol       Date:  2020-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.